您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8420 处方药 8047 非处方药 267 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 调节水、电解质药->电解质补充药
处方药:处方药
包装规格: 50克/1000毫升 100毫升/袋 4袋/盒
计价单位:
   
生产厂家英文名:
Baxter Healthcare Corporation
该药品相关信息网址1:
https://www.rxlist.com/consumer_dextrose/drugs-condition.htm
原产地英文商品名:
Dextrose-Water 50g/1000mL 100mL/bag 4bag/box
原产地英文药品名:
dextrose monohydrate
中文参考商品译名:
葡萄糖注射液 50克/1000毫升 100毫升/袋 4袋/盒
中文参考药品译名:
葡萄糖一水合物
原产地国家批准上市年份:
2005/06/27
英文适应病症1:
Moisture and heat supplement
临床试验期:
完成
中文适应病症参考翻译1:
水分和熱量的補充
药品信息:

---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件(201931317154737.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文葡萄糖注射液处方资料(仅供参考)


【英文名称】
Dextrose-Water Adv

【适用证】

含有右旋糖的静脉内溶液适用于肠胃外补充液体和最小碳水化合物卡路里,这是患者临床状况所要求的。

在此剂型中,5%葡萄糖注射液,USP用作ADD-Vantage小瓶内容物的稀释剂,或使用ADD-Vantage ADDAPTOR封闭20 mm的单剂量小瓶

【用法用量】

剂量取决于患者的年龄,体重和临床状况。

如文献报道,由于高血糖/低血糖的风险增加,儿科患者,特别是新生儿和低出生体重婴儿必须谨慎选择静脉内葡萄糖的剂量和恒定输注速度。

当溶液和容器允许时,应在给药前目视检查肠外药物产品中的颗粒物质和变色。 见预防措施。

【警告和注意事项】

不含电解质的葡萄糖注射剂不应与血液同时通过相同的输液器给药,因为可能发生红细胞的假性凝集。

过量给予无钾溶液可能导致严重的低钾血症。

静脉注射这些溶液会导致液体和/或溶质过载,从而导致血清电解质浓度,过度水合,充血状态或肺水肿的稀释。

稀释状态的风险与施用的肠胃外溶液的电解质浓度成反比。 溶质过载引起外周和肺水肿的充血状态的风险与这些溶液的电解质浓度成正比。

【INDICATIONS AND USAGE】

Intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient.

In this dosage form, 5% Dextrose Injection, USP is intended to be used as a diluent for the contents of an ADD-Vantage vial, or single-dose vials with 20 mm closure using the ADD-Vantage ADDAPTOR

【CONTRAINDICATIONS】

Dextrose Injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

【WARNINGS】

Excessive administration of potassium-free solutions may result in significant hypokalemia.

The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema.

The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered parenteral solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions.

【DOSAGE AND ADMINISTRATION】

The dose is dependent on the age, weight and clinical condition of the patient.

As reported in the literature, the dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low birth weight infants, because of the increased risk of hyperglycemia/hypoglycemia.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See PRECAUTIONS.

---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件(201931317154737.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2019-5-29
附件:
201931317154737.pdf    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com